MétaCan
Menu
Back to cohort
Record W3199044464 · doi:10.1002/fft2.113

Research Profile: Dr. Jeevan K. Prasain

2021· article· en· W3199044464 on OpenAlexaboutno aff
Jeevan K. Prasain

Bibliographic record

VenueFood Frontiers · 2021
Typearticle
Languageen
FieldMedicine
TopicNatural Antidiabetic Agents Studies
Canadian institutionsnot available
Fundersnot available
KeywordsLibrary scienceChemistryTraditional medicineMedicineComputer science

Abstract

fetched live from OpenAlex

Dr. Jeevan K. Prasain is an associate professor of pharmacology and toxicology at the University of Alabama at Birmingham. His current research focuses on delineation of unconventional cyclooxygenase (Cox)-independent prostaglandin (PG) synthesis mechanism, mass spectrometry-based metabolomics/lipidomics, biological activity, and uptake and metabolisms of dietary botanicals in vitro and in vivo. Dr. Prasain received his MSc in chemistry from Tribhuvan University located in Kathmandu, Nepal and went on to obtain his PhD in Japan from the Toyama Medical and Pharmaceutical University in pharmaceutical sciences. During his PhD tenure, he devoted much of his studies to natural product chemistry resulting in the discovery of several novel bioactive diarylheptanoids, subjects he went on to publish in several papers. After the completion of his PhD, he was awarded the Canadian Government Visiting Fellowship at the Biotechnology Research Institute (BRI) in Montreal, Canada to pursue postdoctoral research. During his time at BRI, Dr. Prasain was involved in drug discovery and high throughput screening of bioactive natural products from natural product libraries and their analysis by tandem mass spectrometry. Through this research, Dr. Prasain later went on to be a recipient of a Science and Technology Award at RIKEN in Tokyo Japan where he developed a mass spectrometry method for analysis of antibiotic cytochalasins. Based on his experiences in natural products research, he developed a great interest in dietary polyphenols in the promotion of health and prevention of chronic disease. Dr. Prasain joined the University of Alabama at Birmingham (UAB) as a postdoctoral fellow with Dr. Stephen Barnes in 2001, where he was later promoted to Assistant Professor in 2003. One of his research focuses was on the understanding of antidiabetic effects of puerarin, an isoflavone C-glucoside from Kudzu root and its metabolism and bioavailability. Kudzu root is well-known in traditional Chinese medicine, and various kudzu root based dietary supplements are available in the US market. Prasain's lab, in collaboration with Dr. Elias Meezan, also at UAB, demonstrated that puerarin treatment significantly improves glucose tolerance in C57 BL/6J ob/ob mice, an animal model of Type 2 diabetes mellitus. Specifically, puerarin blunts the rise in blood glucose levels after i.p. administration of glucose. Prasain et al. also found that in contrast to its O-glucoside isomer daidzin, puerarin is essentially absorbed without undergoing metabolism and is excreted in the urine mainly as an unchanged parent. In addition, in collaboration with Dr. Clinton Grubbs at UAB on the role of cranberry juice in bladder cancer prevention in animals, Prasain et al. demonstrated that commercially available cranberry juice concentrate can prevent urinary bladder cancers dose-dependently in N-butyl-N-(4-hydroxybutyl)-nitrosamine (OH-BBN) induced bladder carcinogenesis in rats when compared to the control group. This study also indicated that cranberry compounds once ingested reach the urinary bladder and concentrate in the urine in either the intact or in the metabolized forms and may prevent against the progression of carcinogenesis. This is because bladder cancers occur almost exclusively in the bladder epithelium, which is directly exposed to the urine stored in the bladder. In 2009, Dr. Prasain received an NIH R21 funding for investigating urinary metabolites of cranberry that protect against bladder cancer. The primary focus of this project was to understand what cranberry metabolites stored in the bladder are bioavailable and which metabolites are responsible against bladder carcinogenesis. The other focus of Dr. Prasain's lab is in the area of lipidomics, particularly profiling and characterizing PGs and other signaling lipids using tandem mass spectrometry. Using a combination of genetics, microinjection, and mass spectrometry, the late Dr. Michael Miller's and Dr. Prasain's labs discovered that C. elegans oocytes secrete sperm attractants F-series PGs derived from polyunsaturated fatty acid precursors. This NIH funded research led to an unanticipated discovery that C. elegans and mice generate specific F-series PGs without Cox enzymes. Over the past several years, much of the Dr. Prasain's lab effort has been to identify genes essential for Cox-independent PG synthesis and the signaling mechanisms that regulate PG functions in reproductive biology. The authors declare no conflict of interest.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.152
Threshold uncertainty score0.508

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.012
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0030.002
Open science0.0020.002
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.1520.100

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.354
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueFood FrontiersSame topicNatural Antidiabetic Agents StudiesFrench-language works237,207